BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21505181)

  • 1. Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.
    Mafuvadze B; Benakanakere I; López Pérez FR; Besch-Williford C; Ellersieck MR; Hyder SM
    Cancer Prev Res (Phila); 2011 Aug; 4(8):1316-24. PubMed ID: 21505181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
    Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
    Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dietary apigenin on tumor latency, incidence and multiplicity in a medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced breast cancer model.
    Mafuvadze B; Cook M; Xu Z; Besch-Williford CL; Hyder SM
    Nutr Cancer; 2013; 65(8):1184-91. PubMed ID: 24127693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
    Carroll CE; Benakanakere I; Besch-Williford C; Ellersieck MR; Hyder SM
    Menopause; 2010; 17(1):178-84. PubMed ID: 19629015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of progestin-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors in Sprague-Dawley rats by p53 reactivation and induction of massive apoptosis: a pilot study.
    Benakanakere I; Besch-Williford C; Ellersieck MR; Hyder SM
    Endocr Relat Cancer; 2009 Mar; 16(1):85-98. PubMed ID: 19075036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in sprague-dawley rats.
    Benakanakere I; Besch-Williford C; Carroll CE; Hyder SM
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1157-67. PubMed ID: 20699413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteolin suppresses development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.
    Cook MT; Mafuvadze B; Besch-Williford C; Ellersieck MR; Goyette S; Hyder SM
    Oncol Rep; 2016 Feb; 35(2):825-32. PubMed ID: 26719029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors.
    Mafuvadze B; Liang Y; Besch-Williford C; Zhang X; Hyder SM
    Horm Cancer; 2012 Aug; 3(4):160-71. PubMed ID: 22569706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation.
    Lee O; Choi MR; Christov K; Ivancic D; Khan SA
    Cancer Lett; 2016 Jul; 376(2):310-7. PubMed ID: 27080304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic activity of rat mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene and its inhibition by medroxyprogesterone acetate: possible involvement of antiangiogenic action of medroxyprogesterone acetate in its tumor growth inhibition.
    Oikawa T; Hiragun A; Yoshida Y; Ashino-Fuse H; Tominaga T; Iwaguchi T
    Cancer Lett; 1988 Dec; 43(1-2):85-92. PubMed ID: 2462464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development.
    Carroll CE; Liang Y; Benakanakere I; Besch-Williford C; Hyder SM
    Int J Oncol; 2013 Jan; 42(1):179-87. PubMed ID: 23123638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by 9alpha-fluoromedoroxyprogesterone acetate (FMPA) against mammary carcinoma induced by dimethylbenz[a]anthracene in rats and angiogenesis in the rabbit cornea - comparison with medroxyprogesterone acetate (MPA).
    Uchida M; Tsuboi H; Yamaji T; Murata N; Kohno T; Sugino E; Hibino S; Shimamura M; Oikawa T
    Cancer Lett; 2000 Jun; 154(1):63-9. PubMed ID: 10799740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat.
    Dauvois S; Spinola PG; Labrie F
    Eur J Cancer Clin Oncol; 1989 May; 25(5):891-7. PubMed ID: 2525471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
    Li S; Lévesque C; Geng CS; Yan X; Labrie F
    Breast Cancer Res Treat; 1995 May; 34(2):147-59. PubMed ID: 7647332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
    Iino Y; Ishikawa H; Izuo M; Takikawa H
    Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
    Wu J; Brandt S; Hyder SM
    Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN/PIK3CA genes are frequently mutated in spontaneous and medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumours of tree shrews.
    Xia HJ; He BL; Wang CY; Zhang HL; Ge GZ; Zhang YX; Lv LB; Jiao JL; Chen C
    Eur J Cancer; 2014 Dec; 50(18):3230-42. PubMed ID: 25457635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release low dose medroxyprogesterone acetate (MPA) inhibits the development of mammary tumors induced by dimethyl-benz(a) anthracene in the rat.
    Labrie F; Li S; Bélanger A; Côté J; Mérand Y; Lepage M
    Breast Cancer Res Treat; 1993; 26(3):253-65. PubMed ID: 8251650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats.
    Luo S; Stojanovic M; Labrie C; Labrie F
    Int J Cancer; 1997 Nov; 73(4):580-6. PubMed ID: 9389575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Animal Model of Induced Breast Precancerous Lesion in Tree Shrew.
    Chen M; Ou C; Yang C; Yang W; Qin Q; Jiang W; Tan Q; Mao A; Liao X; Ye X; Wei C
    Biol Pharm Bull; 2019 Apr; 42(4):580-585. PubMed ID: 30674757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.